NYSE: CTRE · Healthcare Facility REITs

CareTrust REIT (CTRE) fair value: undervalued or overvalued?

As of 14 Nov 2026, Faircurve's model values CareTrust REIT (CTRE) at $33.28 a share. The stock last closed at $37.39, which puts the model's fair value 11.0% below the price. On the model's bands that reads as Overvalued.

Revalued . Price is the close of 16 Nov 2026. CareTrust REIT, Inc.

The report adds the live price, the chart against the range the options market prices and the next earnings date. No account needed.

Model fair value$33.28blend of three valuation methods
Last close$37.39NYSE: CTRE
Gap to fair value-11.0%fair value against price
Model verdictOvervaluedevidence grade: High

This week, in three parts

What happenedThe run of 14 Nov 2026 moved the fair value from $31.18 to $33.28 (+6.7%). The model does not yet explain moves on this valuation method.

What the model makes of itThe price of $37.39 is 11.0% above it: Overvalued, on a high evidence grade.

What's nextNext report on 11 Feb 2027. The next weekly run is on Saturday 21 Nov 2026.

What price range does the model give CTRE?

The calibrated range for CTRE over 63 trading days is $26.62 to $39.54. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 13,250 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon.

The model's own range is $30.43 to $36.89.

$25.72$44.99
The shape of the range around the fair value, from 2,000 simulations of the dividend model. Solid line: the fair value, $33.28. Dashed line: the last close, $37.39.

Faircurve Insights · 14 Nov 2026

CareTrust REIT, Inc. (CTRE) operates as a self-managed, publicly traded real estate investment trust. It is classed under Real Estate, Healthcare Facility REITs.

Faircurve's model put the fair value at $33.28 a share on 14 Nov 2026. The previous run, on 7 Nov 2026, gave $31.18, so the fair value moved +6.7%. The model does not yet explain moves on this valuation method. The calibrated range over 63 trading days is $26.62 to $39.54, built from the fair value because there is no live options data for the stock. Ranges built this way held the price 60% of the time at this horizon. The evidence grade is High. For REITs, the grade looks at the dividend record: at least three years of paid dividends with no cut. It does not say whether the fair value is right.

The model compares CareTrust with six companies, each with a fair value of its own on the site: Healthpeak Properties, Inc. (DOC), Omega Healthcare Investors, Inc. (OHI), Healthcare Realty Trust Incorporated (HR), Sabra Health Care REIT, Inc. (SBRA), LTC Properties, Inc. (LTC) and Ventas, Inc. (VTR). Two further comparables, American Healthcare REIT, Inc. (AHR) and Medical Properties Trust, Inc. (MPT), have no verdict on this date. The facts available for this note contain no quality scores for the business, so it cannot report how CareTrust ranks on quality against the peer median.

Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.

The Global Pulse

Faircurve's note after each US session, in your inbox. No account needed.

When does CTRE report earnings, and how has the stock reacted?

CareTrust REIT's next earnings report is scheduled for 11 Feb 2027. Companies can move their dates.

Around its last 8 reports: what the options market priced, and what followed

Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across CTRE's last 8 reports, ignoring direction, was 1.2%.

0%5%10%no quote3.0%12 Feb '25no quote0.7%6 Aug '25no quote0.5%5 Nov '25no quote1.6%12 Feb '26no quote5.4%7 May '266.1%0.2%6 Aug '268.0%0.7%5 Nov '269.9%1.6%9 Nov '26priced before the reportthe move that followed
What the options market priced for each report, against the size of the move that followed. Priced: the move implied by options expiring after the report, on the last quote before it. Followed: the close before the report to the close after. Sizes only, no direction.

How does CTRE compare with similar companies?

The companies in healthcare facility reits closest to CareTrust REIT in market value, each on the same model and the same date.

CompanyLast closeModel fair valueGapModel verdict
AHR American Healthcare REIT, Inc.$58.07$22.90-60.6%Gap wider than 60%
DOC Healthpeak Properties, Inc.$19.84$31.13+56.9%Undervalued
OHI Omega Healthcare Investors, Inc.$47.08$51.39+9.2%Undervalued
HR Healthcare Realty Trust Incorporated$19.32$17.48-9.5%Overvalued
SBRA Sabra Health Care REIT, Inc.$20.35$20.72+1.8%Fairly valued
LTC LTC Properties, Inc.$42.71$56.30+31.8%Undervalued
VTR Ventas, Inc.$88.90$46.80-47.4%Overvalued
MPT Medical Properties Trust, Inc.$1.50$5.43+262.0%Gap wider than 60%

All healthcare facility reit stocks ranked by gap to fair value

CareTrust REIT at a glance

CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust.

Market value
$9.8B
Sector
Real Estate
Industry
Healthcare Facility REITs
Beta to the US market
-0.01
First valued by Faircurve
11 Jul 2026

At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. CTRE was not among them.

How the fair value is worked out: the model values CareTrust REIT three ways and blends them; the range around the fair value comes from 2,000 simulations of the dividend model. The full method is documented here.

What changed in the latest valuation?

On 7 Nov 2026 the model's fair value for CTRE was $31.18. As of 14 Nov 2026 it is $33.28, a change of +6.7%. The model does not yet explain moves on this valuation method. The model revalues every stock it covers each week, and again after an earnings report.

Questions about CareTrust REIT's valuation

Is CareTrust REIT stock undervalued or overvalued?

On Faircurve's model, CTRE reads as Overvalued as of 14 Nov 2026. The model's fair value is $33.28 a share against a last close of $37.39, a gap of -11.0%.

What is CTRE's fair value?

$33.28 a share as of 14 Nov 2026. The fair value blends three methods: a cash-flow multiple against comparable companies, a dividend model, and the value of the properties. The model's own range is $30.43 to $36.89.

What price range does the model give CTRE?

$26.62 to $39.54 over 63 trading days. Ranges built this way held the price 60% of the time across 13,250 past valuations, refreshed 14 Nov 2026.

When does CareTrust REIT report earnings next?

The next report is scheduled for 11 Feb 2027. Companies can move their dates.

How much has CTRE moved on past earnings reports?

Across its last 8 reports the median two session move was 1.2%, ignoring direction. The largest was +5.4% around the report of 7 May 2026.

How confident is the model in this valuation?

The model's evidence grade for CTRE is high. For real estate investment trusts (REITs) the grade looks at the dividend record: at least three years of paid dividends with no cut. It is not a probability that the fair value is right, or that the price reaches it.

The model's own ideas on CTRE

The model holds no idea open on CTRE today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on CTRE with their outcomes. A free account is enough.

Keep reading